Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-type natriuretic peptide receptor B (NPR-B) is a transmembrane receptor that primarily binds C-type natriuretic peptide (CNP). NPR-B is a member of the particulate guanylyl cyclase family and catalyzes the conversion of GTP to cyclic GMP (cGMP) upon ligand binding. It plays critical roles in skeletal development through regulation of cartilage growth plates as well as cardiovascular homeostasis by modulating vascular tone and autonomic control over heart function. Dysfunctional signaling through this pathway has important implications for both skeletal dysplasias and cardiovascular disease states such as hypertension.
Activation of guanylyl cyclase, leading to increased cGMP production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-type Natriuretic Peptide Receptor B (NPR-B).